Targeting deubiquitinase activity with a novel small-molecule inhibitor as therapy for B-cell malignancies.
Targeting deubiquitinase activity with a novel small-molecule inhibitor as therapy for B-cell malignancies. Blood. 2015 Jun 04; 125(23):3588-97.